J. Goldman & Co’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
364,557
+224,269
| +160% | +$9.09M | 0.35% | 76 |
|
|
2025
Q1 | $7.21M | Buy |
140,288
+10,093
| +8% | +$518K | 0.18% | 124 |
|
|
2024
Q4 | $7.21M | Sell |
130,195
-427,305
| -77% | -$23.7M | 0.19% | 130 |
|
|
2024
Q3 | $18.3M | Buy |
557,500
+170,339
| +44% | +$5.6M | 0.51% | 40 |
|
|
2024
Q2 | $10.5M | Buy |
387,161
+223,814
| +137% | +$6.08M | 0.3% | 86 |
|
|
2024
Q1 | $5.94M | Buy |
163,347
+91,003
| +126% | +$3.31M | 0.19% | 97 |
|
|
2023
Q4 | $1.46M | Sell |
72,344
-53,565
| -43% | -$1.08M | 0.06% | 137 |
|
|
2023
Q3 | $2.24M | Buy |
125,909
+69,937
| +125% | +$1.24M | 0.08% | 129 |
|
|
2023
Q2 | $1.01M | Buy |
55,972
+14,399
| +35% | +$260K | 0.04% | 163 |
|
|
2023
Q1 | $523K | Hold |
41,573
| – | – | 0.02% | 184 |
|
|
2022
Q4 | $609K | Hold |
41,573
| – | – | 0.03% | 198 |
|
|
2022
Q3 | $712K | Sell |
41,573
-9,253
| -18% | -$158K | 0.03% | 194 |
|
|
2022
Q2 | $742K | Buy |
50,826
+40,282
| +382% | +$588K | 0.04% | 185 |
|
|
2022
Q1 | $177K | Buy |
+10,544
| New | +$177K | 0.01% | 233 |
|
|
2021
Q4 | – | Sell |
-22,198
| Closed | -$478K | – | 336 |
|
|
2021
Q3 | $478K | Sell |
22,198
-11,553
| -34% | -$249K | 0.02% | 210 |
|
|
2021
Q2 | $978K | Buy |
+33,751
| New | +$978K | 0.04% | 227 |
|